Skip to main content
. 2022 Feb 2;12:1754. doi: 10.1038/s41598-022-05794-8

Table 3.

Patient and data distribution of 74 patients used for training and testing.

Training Validation Test Total
LTP group (n = 34)
Tumor/LTP (positive case)
 No. of tumors 36 5 8 49
 No. of patches 720 100 160 980
Non-Tumor/LTP (Negative class)
 No. of tumors 21 5 8 34
 No. of patches 840 200 320 1360
No LTP group (n = 40)
Non-Tumor/LTP (Negative class)
 No. of tumors 27 5 8 40
 No. of patches 1080 200 320 1600

LTP, local tumor progression.